Cancer
from24/7 Wall St.
1 day agoMerck Price Prediction: Sac-TMT Drug Potential Pushes MRK to $150
Wells Fargo projects Merck stock to reach $150 by end of 2026, driven primarily by sac-TMT's potential to replace chemotherapy across multiple cancer indications and KEYTRUDA's continued expansion.